Genetic Loss of Calcineurin Blocks Mechanical Overload-induced Skeletal Muscle Fiber Type Switching but Not Hypertrophy
Overview
Authors
Affiliations
The serine/threonine phosphatase calcineurin is an important regulator of calcium-activated intracellular responses in eukaryotic cells. In higher eukaryotes, calcium/calmodulin-mediated activation of calcineurin facilitates direct dephosphorylation and nuclear translocation of the transcription factor nuclear factor of activated T-cells (NFAT). Recently, controversy has surrounded the role of calcineurin in mediating skeletal muscle cell hypertrophy. Here we examined the ability of calcineurin-deficient mice to undergo skeletal muscle hypertrophic growth following mechanical overload (MOV) stimulation or insulin-like growth factor-1 (IGF-1) stimulation. Two distinct models of calcineurin deficiency were employed: calcineurin Abeta gene-targeted mice, which show a approximately 50% reduction in total calcineurin, and calcineurin B1-LoxP-targeted mice crossed with a myosin light chain 1f cre knock-in allele, which show a greater than 80% loss of total calcineurin only in skeletal muscle. Calcineurin Abeta-/- and calcineurin B1-LoxP(fl/fl)-MLC-cre mice show essentially no defects in muscle growth in response to IGF-1 treatment or MOV stimulation, although calcineurin Abeta-/- mice show a basal defect in total fiber number in the plantaris and a mild secondary reduction in growth, consistent with a developmental defect in myogenesis. Both groups of gene-targeted mice show normal increases in Akt activation following MOV or IGF-1 stimulation. However, overload-mediated fiber-type switching was dramatically impaired in calcineurin B1-LoxP(fl/fl)-MLC-cre mice. NFAT-luciferase reporter transgenic mice failed to show a correlation between IGF-1- or MOV-induced hypertrophy and calcineurin-NFAT-dependent signaling in vivo. We conclude that calcineurin expression is important during myogenesis and fiber-type switching, but not for muscle growth in response to hypertrophic stimuli.
Franco-Obregon A, Tai Y, Wu K, Iversen J, Wong C Bioengineering (Basel). 2023; 10(8).
PMID: 37627841 PMC: 10451851. DOI: 10.3390/bioengineering10080956.
Roberts M, McCarthy J, Hornberger T, Phillips S, Mackey A, Nader G Physiol Rev. 2023; 103(4):2679-2757.
PMID: 37382939 PMC: 10625844. DOI: 10.1152/physrev.00039.2022.
Li X, Liang C, Yan Y Cells. 2022; 11(19).
PMID: 36231110 PMC: 9562001. DOI: 10.3390/cells11193148.
Measuring cardiomyocyte cell-cycle activity and proliferation in the age of heart regeneration.
Auchampach J, Han L, Huang G, Kuhn B, Lough J, OMeara C Am J Physiol Heart Circ Physiol. 2022; 322(4):H579-H596.
PMID: 35179974 PMC: 8934681. DOI: 10.1152/ajpheart.00666.2021.
Yin H, Guo X, Chen Y, Zeng Y, Mo X, Hong S J Clin Invest. 2022; 132(4).
PMID: 34990405 PMC: 8843707. DOI: 10.1172/JCI152297.